Loading...
•
Dec 31, 2019
HCA Q4 2019 Earnings Report
HCA Healthcare's financial performance was strong, marked by revenue growth and increased profitability.
Key Takeaways
HCA Healthcare reported a revenue of $13.523 billion and net income of $1.071 billion for Q4 2019. Adjusted EBITDA totaled $2.738 billion. Same facility admissions and equivalent admissions increased by 4.7% and 5.0%, respectively.
Revenues reached $13.523 billion, marking an increase from $12.274 billion in Q4 2018.
Net income attributable to HCA Healthcare, Inc. was $1.071 billion, or $3.09 per diluted share.
Adjusted EBITDA amounted to $2.738 billion, up from $2.508 billion in the prior year.
Cash flows from operating activities totaled $2.505 billion.
HCA
HCA
Forward Guidance
HCA issued estimated guidance for 2020, projecting revenues between $53.5 to $55.5 billion, Adjusted EBITDA between $10.25 to $10.65 billion, and EPS between $11.30 to $12.10 per diluted share. Capital expenditures are expected to be $4.0 to $4.2 billion.
Positive Outlook
- Revenues are projected to be between $53.5 and $55.5 billion.
- Adjusted EBITDA is expected to range from $10.25 to $10.65 billion.
- EPS (diluted) is anticipated to be between $11.30 and $12.10 per diluted share.
- Company's guidance is based on current plans and expectations.
- Future dividends are expected to be funded by future cash flows from operations.
Challenges Ahead
- Guidance excludes the impact of items such as gains or losses on sales of facilities.
- Guidance excludes the impact of losses on retirement of debt.
- Guidance excludes the impact of legal claims costs.
- Guidance excludes the impact of impairment of long-lived assets.
- Company's guidance is subject to a number of known and unknown uncertainties and risks.